Evaluation of plaque stability of advanced atherosclerotic lesions in Apo E-deficient mice after treatment with the oral factor Xa inhibitor rivaroxaban

Mediators of Inflammation

Volumn 2011, Issue , 2011, Pages

  Blessing, Erwin ^a   Zhou, Qianxing ^a,b   Bea, Florian ^a   Preusch, Michael ^a   Wang, Hongjie ^a   Isermann, Berend ^a   Shahzad, Khurrum ^a   Katus, Hugo A ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; EARLY GROWTH RESPONSE FACTOR 1; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; RIVAROXABAN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 10A; LIPID; MORPHOLINE DERIVATIVE; THIOPHENE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROTIC PLAQUE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HYPERLIPOPROTEINEMIA TYPE 3; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; THORACIC AORTA; XANTHOMA; ANIMAL; ATHEROSCLEROSIS; BLOOD; DRUG ANTAGONISM; GENETICS; HUMAN; METABOLISM; MOUSE MUTANT; PATHOLOGY; RANDOMIZATION;

MUS;

ANIMALS; ANTICOAGULANTS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; FACTOR XA; FEMALE; HUMANS; LIPIDS; MICE; MICE, KNOCKOUT; MORPHOLINES; PLAQUE, ATHEROSCLEROTIC; RANDOM ALLOCATION; THIOPHENES;

EID: 80052663235     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2011/432080     Document Type: Article

References (40)

1. Perzborn E., Strassburger J., Wilmen A., Pohlmann J., Roehrig S., Schlemmer K., Straub A., In vitro and in vivo studies of the novel antithrombotic agent BAY 59-7939an oral, direct Factor Xa inhibitor Journal of Thrombosis and Haemostasis 2005 3 3 514 521 (Pubitemid 41632877)
2. Gensch C., Hoppe U., Bhm M., Laufs U., Late-breaking clinical trials presented at the American Heart Association Congress in Chicago 2010 Clinical Research in Cardiology 2011 100 1 1 9
3. The EINSTEIN Investigators, Oral rivaroxaban for symptomatic venous thromboembolism New England Journal of Medicine 2010 363 2499 2510
4. Mega J. L., Braunwald E., Mohanavelu S., Burton P., Poulter R., Misselwitz F., Hricak V., Barnathan E. S., Bordes P., Witkowski A., Markov V., Oppenheimer L., Gibson C. M., Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial The Lancet 2009 374 9683 29 38
5. Libby P., Current concepts of the pathogenesis of the acute coronary syndromes Circulation 2001 104 3 365 372 (Pubitemid 32666962)
6. Hansson G. K., Mechanisms of disease: inflammation, atherosclerosis, and coronary artery disease New England Journal of Medicine 2005 352 16 1685 1695
7. Harker L. A., Hanson S. R., Runge M. S., Thrombin hypothesis of thrombus generation and vascular lesion formation American Journal of Cardiology 1995 75 6 12B 17B
8. Bea F., Kreuzer J., Preusch M., Schaab S., Isermann B., Rosenfeld M. E., Katus H., Blessing E., Melagatran reduces advanced atherosclerotic lesion size and may promote plaque stability in apolipoprotein E-deficient mice Arteriosclerosis, Thrombosis, and Vascular Biology 2006 26 12 2787 2792
9. Pfaffl M. W., A new mathematical model for relative quantification in real-time RT-PCR Nucleic acids research 2001 29 9, article e45
10. Davie E. W., Fujikawa K., Kisiel W., The coagulation cascade: Initiation, maintenance, and regulation Biochemistry 1991 30 43 10363 10370
11. Rao L. V. M., Pendurthi U. R., Tissue factor-factor VIIa signaling Arteriosclerosis, Thrombosis, and Vascular Biology 2005 25 1 47 56 (Pubitemid 40054253)
12. Napoli C., De Nigris F., Wallace J. L., Hollenberg M. D., Tajana G., De Rosa G., Sica V., Cirino G., Evidence that protease activated receptor 2 expression is enhanced in human coronary atherosclerotic lesions Journal of Clinical Pathology 2004 57 5 513 516 (Pubitemid 38621797)
13. Borensztajn K., Stiekema J., Nijmeijer S., Reitsma P. H., Peppelenbosch M. P., Spek C. A., Factor Xa stimulates proinflammatory and profibrotic responses in fibroblasts via protease-activated receptor-2 activation American Journal of Pathology 2008 172 2 309 320 (Pubitemid 351282019)
14. Damiano B. P., Cheung W. M., Santulli R. J., Fung-Leung W. P., Ngo K., Ye R. D., Darrow A. L., Derian C. K., De Garavilla L., Andrade-Gordon P., Cardiovascular responses mediated by protease-activated receptor-2 (PAR- 2) and thrombin receptor (PAR-1) are distinguished in mice deficient in PAR-2 or PAR-1 Journal of Pharmacology and Experimental Therapeutics 1999 288 2 671 678 (Pubitemid 29119680)
15. Grandaliano G., Pontrelli P., Cerullo G., Monno R., Ranieri E., Ursi M., Loverre A., Gesualdo L., Schena F. P., Protease-activated receptor-2 expression in IgA nephropathy: a potential role in the pathogenesis of interstitial fibrosis Journal of the American Society of Nephrology 2003 14 8 2072 2083 (Pubitemid 36909915)
16. Masamune A., Kikuta K., Satoh M., Suzuki N., Shimosegawa T., Protease-activated receptor-2-mediated proliferation and collagen production of rat pancreatic stellate cells Journal of Pharmacology and Experimental Therapeutics 2005 312 2 651 658 (Pubitemid 40189563)
17. Cirino G., Cicala C., Bucci M., Sorrentino L., Ambrosini G., DeDominicis G., Altieri D. C., Factor Xa as an interface between coagulation and inflammation: Molecular mimicry of factor Xa association with effector cell protease receptor-1 induces acute inflammation in vivo Journal of Clinical Investigation 1997 99 10 2446 2451 (Pubitemid 27227723)
18. Senden N. H. M., Jeunhomme T. M. A. A., Heemskerk J. W. M., Wagenvoord R., Van't Veer C., Hemker H. C., Buurman W. A., Factor Xa induces cytokine production and expression of adhesion molecules by human umbilical vein endothelial cells Journal of Immunology 1998 161 8 4318 4324 (Pubitemid 28469016)
19. Papapetropoulos A., Piccardoni P., Cirino G., Bucci M., Sorrentino R., Cicala C., Johnson K., Zachariou V., Sessa W. C., Altieri D. C., Hypotension and inflammatory cytokine gene expression triggered by factor Xa-nitric oxide signaling Proceedings of the National Academy of Sciences of the United States of America 1998 95 8 4738 4742 (Pubitemid 28207983)
20. Ruf W., Dorfleutner A., Riewald M., Specificity of coagulation factor signaling Journal of Thrombosis and Haemostasis 2003 1 7 1495 1503
21. Hezi-Yamit A., Wong P. W., Bien-Ly N., Komuves L. G., Prasad K. S. S., Phillips D. R., Sinha U., Synergistic induction of tissue factor by coagulation factor Xa and TNF: evidence for involvement of negative regulatory signaling cascades Proceedings of the National Academy of Sciences of the United States of America 2005 102 34 12077 12082 (Pubitemid 41291131)
22. Daubie V., Cauwenberghs S., Senden N. H. M., Pochet R., Lindhout T., Buurman W. A., Heemskerk J. W. M., Factor Xa and thrombin evoke additive calcium and proinflammatory responses in endothelial cells subjected to coagulation Biochimica et Biophysica Acta-Molecular Cell Research 2006 1763 8 860 869 (Pubitemid 44205273)
23. McLean K., Schirm S., Johns A., Morser J., Light D. R., FXa-induced responses in vascular wall cells are PAR-mediated and inhibited by ZK-807834 Thrombosis Research 2001 103 4 281 297 (Pubitemid 32787020)
24. Johnson K., Aarden L., Choi Y., De Groot E., Creasey A., The proinflammatory cytokine response to coagulation and endotoxin in whole blood Blood 1996 87 12 5051 5060 (Pubitemid 26189846)
25. Wakefield T. W., Strieter R. M., Wilke C. A., Kadell A. M., Wrobleski S. K., Burdick M. D., Schmidt R., Kunkel S. L., Greenfield L. J., Venous thrombosis-associated inflammation and attenuation with neutralizing antibodies to cytokines and adhesion molecules Arteriosclerosis, Thrombosis, and Vascular Biology 1995 15 2 258 268
26. Drffler-Melly J., Schwarte L. A., Ince C., Levi M., Mouse models of focal arterial and venous thrombosis Basic Research in Cardiology 2000 95 6 503 509 (Pubitemid 32013992)
27. Turpie A. G. G., Oral, direct factor Xa inhibitors in development for the prevention and treatment of thromboembolic diseases Arteriosclerosis, Thrombosis, and Vascular Biology 2007 27 6 1238 1247 (Pubitemid 46809411)
28. Nicholson A. C., Nachman R. L., Altieri D. C., Summers B. D., Ruf W., Edgington T. S., Hajjart D. P., Effector cell protease receptor-1 is a vascular receptor for coagulation factor Xa Journal of Biological Chemistry 1996 271 45 28407 28413 (Pubitemid 26374659)
29. Ko F. N., Yang Y. C., Huang S. C., Ou J. T., Coagulation factor Xa stimulates platelet-derived growth factor release and mitogenesis in cultured vascular smooth muscle cells of rat Journal of Clinical Investigation 1996 98 6 1493 1501 (Pubitemid 26322076)
30. Gasic G. P., Arenas C. P., Gasic T. B., Gasic G. J., Coagulation factors X, Xa, and protein S as potent mitogens of cultured aortic smooth muscle cells Proceedings of the National Academy of Sciences of the United States of America 1992 89 6 2317 2320
31. Kaiser B., DX-9065a, a direct inhibitor of factor Xa Cardiovascular Drug Reviews 2003 21 2 91 104 (Pubitemid 36935488)
32. Ragosta M., Gimple L. W., Gertz S. D., Dunwiddie C. T., Vlasuk G. P., Haber H. L., Powers E. R., Roberts W. C., Sarembock I. J., Specific factor Xa inhibition reduces restenosis after balloon angioplasty of atherosclerotic femoral arteries in rabbits Circulation 1994 89 3 1262 1271 (Pubitemid 24076554)
33. Jang Y., Guzman L. A., Lincoff A. M., Gottsauner-Wolf M., Forudi F., Hart C. E., Courtman D. W., Ezban M., Ellis S. G., Topol E. J., Influence of blockade at specific levels of the coagulation cascade on restenosis in a rabbit atherosclerotic femoral artery injury model Circulation 1995 92 10 3041 3050
34. Lyle E. M., Fujita T., Conner M. W., Connolly T. M., Vlasuk G. P., Lynch J. L., Effect of inhibitors of factor X(a) or platelet adhesion, heparin, and aspirin on platelet deposition in an atherosclerotic rabbit model of angioplasty injury Journal of Pharmacological and Toxicological Methods 1995 33 1 53 61
35. Kopp C. W., Hlzenbein T., Steiner S., Marculescu R., Bergmeister H., Seidinger D., Mosberger I., Kaun C., Cejna M., Horvat R., Wojta J., Maurer G., Binder B. R., Breuss J. M., Ecker R. C., De Martin R., Minar E., Inhibition of restenosis by tissue factor pathway inhibitor: in vivo and in vitro evidence for suppressed monocyte chemoattraction and reduced gelatinolytic activity Blood 2004 103 5 1653 1661 (Pubitemid 38268956)
36. Tomasek J. J., Gabbiani G., Hinz B., Chaponnier C., Brown R. A., Myofibroblasts and mechano: Regulation of connective tissue remodelling Nature Reviews Molecular Cell Biology 2002 3 5 349 363 (Pubitemid 34619269)
37. Xiong J., Zhu Z., Liu J., Wang Y., Li Z., Role of protease activated receptor-2 expression in renal interstitial fibrosis model in mice Journal of Huazhong University of Science and Technology. Medical Sciences 2005 25 5 523 526
38. Bea F., Blessing E., Shelley M. I., Shultz J. M., Rosenfeld M. E., Simvastatin inhibits expression of tissue factor in advanced atherosclerotic lesions of apolipoprotein E deficient mice independently of lipid lowering: potential role of simvastatin-mediated inhibition of Egr-1 expression and activation Atherosclerosis 2003 167 2 187 194 (Pubitemid 36773519)
39. Gu L., Okada Y., Clinton S. K., Gerard C., Sukhova G. K., Libby P., Rollins B. J., Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice Molecular Cell 1998 2 2 275 281 (Pubitemid 128373654)
40. Boring L., Gosling J., Cleary M., Charo I. F., Decreased lesion formation in CCR2(-/-) mice reveals a role for chemokines in the initiation of atherosclerosis Nature 1998 394 6696 894 897 (Pubitemid 28410911)